Takeda Introduces Vedolizumab In India Amid Signs Of Gear Shift

 
• By Anju Ghangurde

Takeda launches blockbuster gastrointestinal drug vedolizumab in India, stepping up the tempo on the back of the local base provided by its acquisition of Shire. More expansion in the country appears to be in store for the Japanese firm.  

Gears growth (Cherries/Shuttertock.com)
Takeda Appears Set To Shift Gears in India • Source: Shutterstock

More from Business

More from Scrip